FDA Limits Use of Iressa for Non-Small Cell Lung Cancer

Gefitinib fails to improve survival in studies, and use is limited to patients showing current or past benefit, according to the FDA.Yael Waknine

Continue to FDA Limits Use of Iressa for Non-Small Cell Lung Cancer on Medscape Headlines.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz